Seer (SEER) EBITDA (2020 - 2026)
Seer (SEER) recorded quarterly EBITDA of -$17.4 million in Q1 2026, down 8.73% quarter-over-quarter from -$16.0 million in Q4 2025, and up 12.23% on a YoY basis from -$15.5 million in Q1 2025.
Seer (SEER) EBITDA (2020 - 2026) Analysis & Trends
Seer's EBITDA history runs 7 years deep, the most recent figure standing at -$17.4 million for Q1 2026.
- In Q1 2026, EBITDA rose 12.23% year-over-year to -$17.4 million; the TTM figure through Mar 2026 stood at -$70.9 million (up 16.68% YoY), while the FY2025 annual figure was -$73.3 million, up 15.06% from the prior year.
- EBITDA was -$17.4 million for Q1 2026 at Seer, down from -$16.0 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$16.0 million in Q4 2025 to a low of -$25.3 million in Q1 2022.
- Historically, EBITDA has averaged -$20.9 million across 5 years, with a median of -$21.0 million in 2024.
- The sharpest annual moves came in 2022 and 2025: EBITDA tumbled 53.98% in 2022, then gained 28.71% in 2025.
- A 5-year view of EBITDA shows it stood at -$21.1 million in 2022, then gained by 20.81% to -$16.7 million in 2023, then sank by 34.14% to -$22.4 million in 2024, then increased by 28.71% to -$16.0 million in 2025, then declined by 8.73% to -$17.4 million in 2026.
- The last three EBITDA figures came in at -$17.4 million (Q1 2026), -$16.0 million (Q4 2025), and -$18.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | -17.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.36 Mn |
| Dec 31, 2025 | -15.97 Mn |
| Sep 30, 2025 | -18.11 Mn |
| Jun 30, 2025 | -19.42 Mn |
| Mar 31, 2025 | -19.78 Mn |
| Dec 31, 2024 | -22.40 Mn |
| Sep 30, 2024 | -19.91 Mn |
| Jun 30, 2024 | -22.96 Mn |
| Mar 31, 2024 | -21.01 Mn |
| Dec 31, 2023 | -16.70 Mn |
| Sep 30, 2023 | -20.85 Mn |
| Jun 30, 2023 | -24.87 Mn |
| Mar 31, 2023 | -22.80 Mn |
| Dec 31, 2022 | -21.08 Mn |
| Sep 30, 2022 | -23.56 Mn |
| Jun 30, 2022 | -23.70 Mn |
| Mar 31, 2022 | -25.34 Mn |
| Dec 31, 2021 | -20.27 Mn |
| Sep 30, 2021 | -18.36 Mn |
| Jun 30, 2021 | -16.68 Mn |